Compared to Estimates, Royalty Pharma (RPRX) Q3 Earnings: A Look at Key Metrics

Royalty Pharma (RPRX) reported $735 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 15.4$1.04 for the same period compares to $0.79 a year ago.The reported revenue represents a surprise of +3.39$710.89 million. With the consensus EPS estimate being $0.95, the EPS surprise was +9.47%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to det ...